[Role of biomarkers in the detection of sub-clinical myocardial injury: H-FABP and radiofrequency ablation of ventricular arrhythmias].
The importance of biomarker assay such as cardiac troponins and H-FABP is assuming a pivotal role not only in the diagnosis and follow-up of patients with acute coronary syndromes. Radiofrequency (RF) ablation represents a widely used method for the non pharmacologic treatment of arrhythmias.We report a case of a patient complaining of life-threatening arrhythmias treated by RF in whom temporal changes of cardiac biomarkers was determined after the procedure.
Istituto di Fisiologia Clinica CNR e Fondazione Toscana Gabriele Monasterio, Pisa. danielag@ifc.cnr.it
Daniela
D
Giannessi
Marcello
M
Piacenti
Maristella
M
Maltinti
Andrea
A
Rossi
Pietro
P
Di Cecco
Umberto
U
Startari
Manuela
M
Cabiati
Luca
L
Panchetti
Silvia
S
Del Ry
Maria-Aurora
MA
Morales
D000368:Aged; D001145:Arrhythmias, Cardiac / Q000097:blood* / Q000601:surgery*; D015415:Biomarkers / Q000097:blood; D017115:Catheter Ablation; D050556:Fatty Acid-Binding Proteins / Q000097:blood*; D006801:Humans; D008297:Male
D015415:Biomarkers; D050556:Fatty Acid-Binding Proteins